Enhanced morphine analgesia in mice lacking β-arrestin 2 LM Bohn, RJ Lefkowitz, RR Gainetdinov, K Peppel, MG Caron, FT Lin Science 286 (5449), 2495-2498, 1999 | 1229 | 1999 |
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence LM Bohn, RR Gainetdinov, FT Lin, RJ Lefkowitz, MG Caron Nature 408 (6813), 720-723, 2000 | 1110 | 2000 |
Desensitization of G protein–coupled receptors and neuronal functions RR Gainetdinov, RT Premont, LM Bohn, RJ Lefkowitz, MG Caron Annu. Rev. Neurosci. 27, 107-144, 2004 | 1029 | 2004 |
Morphine side effects in β-arrestin 2 knockout mice KM Raehal, JKL Walker, LM Bohn Journal of Pharmacology and Experimental Therapeutics 314 (3), 1195-1201, 2005 | 679 | 2005 |
Crystal structure of the human cannabinoid receptor CB1 T Hua, K Vemuri, M Pu, L Qu, GW Han, Y Wu, S Zhao, W Shui, S Li, ... Cell 167 (3), 750-762. e14, 2016 | 563 | 2016 |
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants F Xu, RR Gainetdinov, WC Wetsel, SR Jones, LM Bohn, GW Miller, ... Nature neuroscience 3 (5), 465-471, 2000 | 514 | 2000 |
Bias factor and therapeutic window correlate to predict safer opioid analgesics CL Schmid, NM Kennedy, NC Ross, KM Lovell, Z Yue, J Morgenweck, ... Cell 171 (5), 1165-1175. e13, 2017 | 474 | 2017 |
Crystal structures of agonist-bound human cannabinoid receptor CB1 T Hua, K Vemuri, SP Nikas, RB Laprairie, Y Wu, L Qu, M Pu, A Korde, ... Nature 547 (7664), 468-471, 2017 | 470 | 2017 |
Crystal structure of the human cannabinoid receptor CB2 X Li, T Hua, K Vemuri, JH Ho, Y Wu, L Wu, P Popov, O Benchama, ... Cell 176 (3), 459-467. e13, 2019 | 345 | 2019 |
Differential mechanisms of morphine antinociceptive tolerance revealed in βarrestin-2 knock-out mice LM Bohn, RJ Lefkowitz, MG Caron Journal of Neuroscience 22 (23), 10494-10500, 2002 | 328 | 2002 |
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance KM Raehal, CL Schmid, CE Groer, LM Bohn Pharmacological reviews 63 (4), 1001-1019, 2011 | 290 | 2011 |
Biased agonism: An emerging paradigm in GPCR drug discovery Z Rankovic, TF Brust, LM Bohn Bioorganic & medicinal chemistry letters 26 (2), 241-250, 2016 | 283 | 2016 |
An opioid agonist that does not induce μ-opioid receptor—arrestin interactions or receptor internalization CE Groer, K Tidgewell, RA Moyer, WW Harding, RB Rothman, ... Molecular pharmacology 71 (2), 549-557, 2007 | 280 | 2007 |
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice RR Gainetdinov, LM Bohn, TD Sotnikova, M Cyr, A Laakso, AD Macrae, ... Neuron 38 (2), 291-303, 2003 | 264 | 2003 |
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo CL Schmid, KM Raehal, LM Bohn Proceedings of the National Academy of Sciences 105 (3), 1079-1084, 2008 | 261 | 2008 |
Muscarinic supersensitivity and impaired receptor desensitization in G protein–coupled receptor kinase 5–deficient mice RR Gainetdinov, LM Bohn, JKL Walker, SA Laporte, AD Macrae, ... Neuron 24 (4), 1029-1036, 1999 | 254 | 1999 |
Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures T Hua, X Li, L Wu, C Iliopoulos-Tsoutsouvas, Y Wang, M Wu, L Shen, ... Cell 180 (4), 655-665. e18, 2020 | 249 | 2020 |
Enhanced rewarding properties of morphine, but not cocaine, in βarrestin-2 knock-out mice LM Bohn, RR Gainetdinov, TD Sotnikova, IO Medvedev, RJ Lefkowitz, ... Journal of Neuroscience 23 (32), 10265-10273, 2003 | 241 | 2003 |
Opioid receptor homo-and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer D Wang, X Sun, LM Bohn, W Sadee Molecular pharmacology 67 (6), 2173-2184, 2005 | 222 | 2005 |
Fulfilling the promise of" biased" G protein–coupled receptor agonism LM Luttrell, S Maudsley, LM Bohn Molecular pharmacology 88 (3), 579-588, 2015 | 207 | 2015 |